期刊文献+

Failure to Inactivate CDK Activity Is Responsible for the Enhanced Apoptotic Response in U937 Cells Mediated by Silencing ATM Gene 被引量:1

Failure to Inactivate CDK Activity Is Responsible for the Enhanced Apoptotic Response in U937 Cells Mediated by Silencing ATM Gene
下载PDF
导出
摘要 Silencing ATM gene gave rise to enhanced apoptotic response to irradiation and i rradiation like chemotherapy agents, this paper explored the crucial identities of the molecular elements responsible for the enhanced apoptotic response in U937 cells mediated by silencing ATM gene. Two U937 cell mutants named U937 ASPI3K (ATM, negative) and U937 pZeosv2(+) (ATM, wild type) were used as a cell model system to identify the critical molecule(s) responsible for the varied apoptotic response in the absence or presence of ATM gene. Apoptosis was examined by measuring concentrations of free nucleosome in U937 cells. Western blot was employed to measure nuclear protein abundance of CDC25A, CDC25B, CDC25C, total p34cdc2, p34cdc2 (Thr 161) or p34cdc2 (Thr 14,Tyr 15). RT PCR was used to estimate CDC25 transcript levels. U937 ASPI3K exhibited an enhanced apoptotic response to lower dosage of irradiation, which could not be blocked by protein synthesis inhibitor. Protein serine threonine phosphatase inhibitor or cyclin dependent kinase (CDK) inhibitors, on the other hand, abolished the enhancement indicated that protein phosphorylation/dephosphorylation modification and CDK activity are required for the enhanced apoptotic response in the absence of ATM gene. Upon irradiation, p34cdc2 in U937 pZeosv2 (+) was maintained in an inactive state by phosphorylation on threonine 14 (Thr 14) and tyrosine 15 (Tyr 15), which was associated with a dramatic decrease of nuclear CDC25A, CDC25B and CDC25C proteins. In contrast, p34cdc2 in U937 ASPI3K maintained in an active state by dephosphorylation on threonine 14 (Thr 14) and tyrosine 15 (Tyr 15), which was associated with constant nuclear CDC25A, CDC25B and CDC25C protein abundance before and after irradiation. The responsive decrease of nuclear CDC25 proteins occurred at the post transcription level. Silencing ATM gene blocks the responsive decrease of nuclear CDC25 proteins, which is responsible for failure to inactivate p34cdc2 after irradiation. Active p34cdc2 and CDK2, in turn, acts as the death executors to trigger apoptosis. In abstract, aberrantly activated CDK activity is the critical molecular mechanism central to enhanced apoptotic responses in the absence of ATM gene. Silencing ATM gene gave rise to enhanced apoptotic response to irradiation and i rradiation like chemotherapy agents, this paper explored the crucial identities of the molecular elements responsible for the enhanced apoptotic response in U937 cells mediated by silencing ATM gene. Two U937 cell mutants named U937 ASPI3K (ATM, negative) and U937 pZeosv2(+) (ATM, wild type) were used as a cell model system to identify the critical molecule(s) responsible for the varied apoptotic response in the absence or presence of ATM gene. Apoptosis was examined by measuring concentrations of free nucleosome in U937 cells. Western blot was employed to measure nuclear protein abundance of CDC25A, CDC25B, CDC25C, total p34cdc2, p34cdc2 (Thr 161) or p34cdc2 (Thr 14,Tyr 15). RT PCR was used to estimate CDC25 transcript levels. U937 ASPI3K exhibited an enhanced apoptotic response to lower dosage of irradiation, which could not be blocked by protein synthesis inhibitor. Protein serine threonine phosphatase inhibitor or cyclin dependent kinase (CDK) inhibitors, on the other hand, abolished the enhancement indicated that protein phosphorylation/dephosphorylation modification and CDK activity are required for the enhanced apoptotic response in the absence of ATM gene. Upon irradiation, p34cdc2 in U937 pZeosv2 (+) was maintained in an inactive state by phosphorylation on threonine 14 (Thr 14) and tyrosine 15 (Tyr 15), which was associated with a dramatic decrease of nuclear CDC25A, CDC25B and CDC25C proteins. In contrast, p34cdc2 in U937 ASPI3K maintained in an active state by dephosphorylation on threonine 14 (Thr 14) and tyrosine 15 (Tyr 15), which was associated with constant nuclear CDC25A, CDC25B and CDC25C protein abundance before and after irradiation. The responsive decrease of nuclear CDC25 proteins occurred at the post transcription level. Silencing ATM gene blocks the responsive decrease of nuclear CDC25 proteins, which is responsible for failure to inactivate p34cdc2 after irradiation. Active p34cdc2 and CDK2, in turn, acts as the death executors to trigger apoptosis. In abstract, aberrantly activated CDK activity is the critical molecular mechanism central to enhanced apoptotic responses in the absence of ATM gene.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2002年第3期193-196,共4页 华中科技大学学报(医学英德文版)
基金 the National NaturalScience Foundation of China (Serial No.3 980 0 1 49)
关键词 apoptosis cyclin dependent kinase p34cdc2 oligonucleotide antisense ATM CDC25 apoptosis cyclin dependent kinase p34cdc2 oligonucleotide, antisense, ATM CDC25
  • 相关文献

参考文献6

  • 1周剑锋,刘文励,汤屹,戴琪琳,孙岚.稳定表达反义ATM/PI3K细胞系U937-ASPI3K的建立[J].中国实验血液学杂志,2001,9(1):22-25. 被引量:6
  • 2Zhou Jianfeng,Liu Wenli,Sun Lan,Sun Hanying,Tang Yi.Multiple defects of cell cycle checkpoints in U937-ASPI3K, an U937 cell mutant stably expressing anti-sense ATM gene cDNA[J].Journal of Tongji Medical University.2000(4)
  • 3Morgen SE,Lovly C,Pandita T K et al.Fragments of ATM which have dominant -negative or complementing activity[].Molecular and Cellular Biology.1997
  • 4Lopez-Girona A,Furnari B,Mondesert O et al.Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein[].Nature.1999
  • 5O’ Connor P M,Fan S.DNA damage checkpoints:implications for cancer therapy[].Progress in Cell Cycle Research.1996
  • 6Shapiro G I,Harper J W.Anticancer drug targets:cell cycle and checkpoint control[].The Journal of Clinical Investigation.1999

二级参考文献10

  • 1Shiloh Y. Ataxia-telangiectasia:closer to unraveling the mys-tery. Eur J Hum Genet, 1995; 3:116- 138
  • 2Harnden DG. The nature of ataxia-telangiectasia: problems andprospectives. Int JRadiat Biol, 1994; 66(6 Suppl):S13- 19
  • 3Savitsky K, Bar-Shira S, Gilad G, et al. A single ataxia-telangiectasia gene with aproduct similar to PI-3 kinase. Science,1995; 268:1749 - 1753
  • 4Savitsky K, Sfez S, Tagle DA, et al. The complete sequenceof the coding region ofthe ATM gene reveals similarity to cellcycle regulators in different species. Hum MolGenet, 1995; 4:2025 - 2032
  • 5Morgan SE, Lovly C, Pandita TK, et al. Fragments of ATMwhich have dominant-negativeor complementing activity. MolCell Biol, 1997; 17:2020-2029
  • 6Boral AL, Dessain S, Chabner BA. Clinical evaluation of bio-logically targeteddrugs: obstacles and opportunities. CancerChemother Pharmacol, 1998; 42(Suppl) :S3 - S21
  • 7Zhang N, Chen P, Gatei M, et al. An anti-sense construct offull length ATM cDNAimposes a radiosensitive phenotype onnormal cells. Oncogene, 1998; 17:811 -818
  • 8Shiloh Y, Parshad R, Sarford KK, et al. Carrier detection inataxia-telangiectasia.Lancet, 1986; 1:689 - 690
  • 9O′Connor PM, Fan S. DNA damage checkpoints: implicationsfor cancer therapy, ProgCell Cycle Res, 1996; 2:165 - 173
  • 10Fan S, Chang JK, Smith ML, et al. Cells lacking CIP1/WAF1 genes exhibitpreferential sensitivity to cisplatin andnitrogen mustard. Oncogene, 1997; 14:2127 - 2136

共引文献5

同被引文献1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部